GABA is a neuroinhibitory substance produced in the gastrointestinal tract. Of all brain nerve endings, 24-45% may be GABAergic. For 20 years, it was postulated that hepatic encephalopathy was the result of increased GABAergic tone in the brain. However, experimental work is changing perceptions regarding the activity of the GABA receptor complex in cirrhosis.